Search

everythinglearnresearchcommunity

for

Search:↓

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Injectable platelet-rich fibrin effectively improves hair density and scalp symptoms in androgenetic alopecia.

The multi-injection plate is a less painful and more efficient method for treating patchy hair loss.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Alpha-blocker therapy may not be needed long-term when combined with finasteride for BPH.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

Baricitinib was effective in treating both early and late onset alopecia areata.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Oral baricitinib is effective and safe for treating alopecia areata.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Finasteride helps improve treatment for benign prostatic hyperplasia.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

Upadacitinib improved multiple immune-related conditions in one patient.